Bouncing back from inhaled nitric oxide

Pediatric Critical Care Medicine

Volumn 5, Issue 3, 2004, Pages 294-295

  Lorts, Angela ^a   Pearl, Jeffrey M ^a   Shanley, Thomas P ^a  

^a CINCINNATI CHILDREN S HOSPITAL RESEARCH FOUNDATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NITRIC OXIDE;

CHEMICALLY INDUCED DISORDER; CHILD; DRUG EFFECT; HUMAN; INHALATIONAL DRUG ADMINISTRATION; METABOLISM; NOTE; PULMONARY HYPERTENSION; VASCULAR RESISTANCE; WITHDRAWAL SYNDROME;

ADMINISTRATION, INHALATION; CHILD; HUMANS; HYPERTENSION, PULMONARY; NITRIC OXIDE; SUBSTANCE WITHDRAWAL SYNDROME; VASCULAR RESISTANCE;

EID: 5144233478     PISSN: 15297535     EISSN: 19473893     Source Type: Journal    
DOI: 10.1097/01.PCC.0000126672.51573.F0     Document Type: Editorial

References (9)

1. Thelitz S, Oishi P, Sanchez LS, et al: Phosphodiesterase-3 inhibition prevents the increase in pulmonary vascular resistance following inhaled nitric oxide withdrawal in lambs. Pediatr Crit Care Med 2004; 5:234-239
2. Arnold WP, Mittal CK, Katsuki S, et al: Nitric oxide activates guanylate cyclase and increases guanosine 3'5'-cyclic monophosphate levels in various tissue preparations. Proc Natl Acad Sci U S A 1977; 74:3203-3207
3. Oka M, et al: Altered vasoreactivity in lungs isolated from rats exposed to nitric oxide gas. Am J Physiol 1996; 27:L419-L424
4. Pearl JM, Nelson DP, Raake JL, et al: Inhaled nitric oxide increases endothelin-1 levels: A potential cause of rebound pulmonary hypertension. Crit Care Med 2002; 30:89-93
5. Ivy D, Kinsella J, Ziegler J, et al: Dipyridamole attenuates rebound pulmonary hypertension after inhaled nitric oxide withdrawal in postoperative congenital heart disease. J Thorac Cardiovasc Surg 1998; 115:875-882
6. Ziegler JW, Ivy DD, Wiggins JW, et al: Effects of dipyridamole and inhaled nitric oxide in pediatric patients with pulmonary hypertension. Am J Respir Crit Care Med 1998; 158: 1388-1395
7. Atz AM, Wessel DL: Sildenafil ameliorates effects of inhaled nitric oxide withdrawal. Anesthesiology, 1999; 91:307-310
8. Stocker C, Penny DJ, Brizard CP, et al: Intravenous sildenafil and inhaled nitric oxide: A randomised trial in infants after cardiac surgery. Intensive Care Med 2003; 29:1996-2003
9. Pearl JM, Wellmann SA, McNamara JL, et al: Bosentan prevents hypoxia-reoxygenationinduced pulmonary hypertension and improves pulmonary function. Ann Thorac Surg 1999; 68:1714-1722